Frenchtown, NJ, United States of America

Michael A Plotkin

USPTO Granted Patents = 2 


Average Co-Inventor Count = 15.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Innovations by Michael A. Plotkin

Introduction

Michael A. Plotkin is an accomplished inventor based in Frenchtown, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target specific receptors related to various health conditions. With a total of two patents to his name, Plotkin's work is focused on addressing critical health issues such as diabetes, obesity, and related disorders.

Latest Patents

One of Plotkin's latest patents is for substituted spiropiperidinyl compounds, which are useful as GPR120 agonists. This invention relates to compounds that can be utilized in treating or preventing diabetes, hyperlipidemia, obesity, and inflammation-related disorders. The compounds are designed to act as agonists of the G-protein coupled receptor GPR120, and the patent also includes pharmaceutical compositions and methods of treatment.

Another notable patent by Plotkin involves spiroxazolidinone compounds. These substituted spirocyclic amines serve as selective antagonists of the somatostatin subtype receptor 5 (SSTR5). They are beneficial for the treatment, control, or prevention of disorders that respond to SSTR5 antagonism, including Type 2 diabetes, insulin resistance, lipid disorders, obesity, atherosclerosis, Metabolic Syndrome, depression, and anxiety.

Career Highlights

Michael A. Plotkin is currently associated with Merck Sharp & Dohme Corporation, a leading global healthcare company. His work at Merck has allowed him to focus on innovative solutions that address pressing health challenges.

Collaborations

Throughout his career, Plotkin has collaborated with notable colleagues, including Joseph Leslie Duffy and Jianming Bao. These collaborations have contributed to the advancement of his research and the successful development of his patented inventions.

Conclusion

Michael A. Plotkin's contributions to pharmaceutical innovations demonstrate his commitment to improving health outcomes through targeted therapies. His patents reflect a deep understanding of complex biological systems and a dedication to addressing significant health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…